Latest filing published 16 Mar 2020 for Enliven Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -68.4%Entry US$8.90 · Close at T+365 US$2.81
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Mette Kirstine Agger: trading record in brief
Mette Kirstine Agger is a declared insider at 3 companies; the most frequent names are scPharmaceuticals Inc., Enliven Therapeutics, Inc. and Trevi Therapeutics, Inc. The record holds 7 filings, for trades running from 21 November 2017 to 16 March 2020.
The open-market record is one-sided, with 3 purchases worth €13.8M and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2020 alone, the filings show 1 purchase and no sales.
A typical purchase (the median) is worth €3.3M. On 3 out of 3 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The latest filing, published on 16 March 2020, reports an open-market purchase of €2.7M in Enliven Therapeutics, Inc. The median gap between trade and publication is zero days: most filings appear on the same day. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Mette Kirstine Agger
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,245,222 sharesCommon StockSEC:0000899243-20-008492:0
- 187,500 shares@ US$16.00100.0% of flowCommon StockSEC:0000899243-20-008492:1Canonical exit: 14 Jun 2020 (T+90)
- 776,544 sharesCommon StockSEC:0000899243-19-013253:0
- 375,000 shares@ US$10.00100.0% of flowCommon StockSEC:0000899243-19-013253:1Canonical exit: 7 Aug 2019 (T+90)
- 654,762 shares@ US$14.00100.0% of flowCommon StockSEC:0000899243-18-003707:0Canonical exit: 19 Feb 2018 (T+90)
- 1,544,858 sharesCommon StockSEC:0000899243-17-027196:0
- 984,366 sharesCommon StockSEC:0000899243-17-027196:1
7 of 6 declarations
